Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.
Neveu, C
Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. [electronic resource] - British journal of pharmacology Oct 2014 - 4425-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5381
10.1111/bph.12808 doi
Amino Acid Sequence
Animals
CHO Cells
Cricetinae
Cricetulus
Humans
Models, Molecular
Molecular Sequence Data
Mutagenesis, Site-Directed
Neuropeptides--metabolism
Oligopeptides--metabolism
Receptors, Adrenergic, beta-2--chemistry
Receptors, G-Protein-Coupled--agonists
Sequence Alignment
Structure-Activity Relationship
Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. [electronic resource] - British journal of pharmacology Oct 2014 - 4425-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5381
10.1111/bph.12808 doi
Amino Acid Sequence
Animals
CHO Cells
Cricetinae
Cricetulus
Humans
Models, Molecular
Molecular Sequence Data
Mutagenesis, Site-Directed
Neuropeptides--metabolism
Oligopeptides--metabolism
Receptors, Adrenergic, beta-2--chemistry
Receptors, G-Protein-Coupled--agonists
Sequence Alignment
Structure-Activity Relationship